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[Basic facts and context
Antimicrobial resistance is a major threat that
medicine is now facing because bacteria have
developed a strong defensive response to the
increasing use of antibiotics. Bacteria have been
able (i) to transfer to pathogens resistance genes
naturally present in antibiotic producing organisms
and the environment, and (ii) to evolve pre-existing
enzymes to inhibit recently developed synthetic
antibiotics. Resistance affects all types of antibi-
otics. In contrast, innovation in antibiotic research
faded abruptly in the 1980s. Thus, we face situa-
tions in which bacteria resistant to most, if not all,
antibiotics can cause serious infections.
Early demonstrationsThe relationship between antibiotic usage and bac-
terial resistance is supported by chronological,
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http://dx.doi.org/10.1016/j.jiph.2013.04.001iological, and epidemiological long known evi-
ences. Commensal bacteria are ﬁrst impacted
y antibiotics during treatments [1]. Susceptible
acteria are replaced by resistant ones which dis-
eminate to innate materials or other hosts and
ransfer resistance genes to pathogens.
Commensal resistant enteric bacteria can con-
aminate the food chain products during slaugh-
ering [2] just as salmonella, campylobacter,
isteria, or entero-haemorragic Escherichia coli.
lso, because manure is often dispersed on vegetal
ultures and crops, animal resistant bacteria can
each vegetarian food [3].
Meat and vegetables contain frequently signiﬁ-
ant amounts of resistant bacteria. Our gut is likely
o be seeded daily with many new strains of resis-
ant bacteria. When volunteers eat only sterile
oods, their bowel ﬂora rapidly changes so they
hen only carry low counts of resistant fecal E. coli
4].
Bacteria resistant to tetracycline rapidly
merged in chickens when they were feed with
hat drug, and these bacteria transmit from
hicken to chicken and to men [5]. Decades ago it
as already shown that when pigs were feed with a
ew antibiotic (streptotricin), bacteria containing
peciﬁc resistance genes were readily isolated in
for Health Sciences. Published by Elsevier Ltd. All rights reserved.
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(ntimicrobial resistance in the food chain and the A
ll animals from the farm, then in the farmers,
nd in inhabitants of the village. Some women
iving nearby suffered from urinary tract infections
aused by strains carrying that speciﬁc resistance
ene [6].
However, doubts are still raised by some on the
ole of the food chain in resistance in human bacte-
ia. They argue that contributor to resistance in
umans is entirely the human use of antibiotics and
hat antibiotic use in animals and transmission of
esistant animal strains, or genes, through the food
hain could only be a marginal phenomenon, if ever
t occurs.
ecent evidences
ecently, evidences of impact of antimicrobial
se in food animals on human health have been
eviewed [7]. Genetic rearrangements in bacte-
ia are frequent with bacteria transferred between
nimals and humans. Thus, resistant bacteria and
enetic constructions are often different in the
onor animals and in the recipient humans. This
eads to the erroneous conclusion that no transfer
as occurred. In this ﬁeld, ‘‘no proof of trans-
er’’ is not the same as ‘‘a proof of no transfer’’.
he debate relationship on the role of animal
ntibiotics to resistance in humans is protracted,
articularly in the United States, where action
ags far behind that of the European Union, where
he ‘‘precautionary principle,’’ is a guiding tenet
f public health, even though the Swann report
8] from the UK showed in the 1960s a clear
ink between antibiotic use in food animals and
uman disease and deaths and made many impor-
ant recommendation to curb antibiotic use in food
nimals. Things might however be changing [9].
Recent studies and evidence is best focussed on
i) frequency of enterobacteria producing extended
pectrum beta-lactamases (E-ESBL) or resistant to
uoroquinolones (both major threat for humans) in
ood chain animals (FCA), (ii) role of density of fecal
-ESBL in terms of risks, (iii) evidences for transfer
etween animals and humans, and (iv) characteris-
ics of organic FCA in terms of resistance.
esistant Escherichia coli in food chain
nimals
. coli causes not only very common community
nfections such as urinary tract infections (UTI),
ut yearly also millions of severe and life threat-
ning infections such as blood stream infections.
n Australia, ﬂuoroquinolones have been used in
[
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eople for over 30 years but the use of ﬂuoro-
uinolones is banned in food production animals.
evels of ﬂuoroquinolone resistance in both com-
unity and healthcare acquired E. coli infections
re low (∼5%) in contrast to nearly all other
ountries where ﬂuoroquinolone resistance rates
re often very much higher. This is despite the over-
ll use of antibiotics per capita being relatively high
n Australia [10]. Also, there is also almost no ﬂuoro-
uinolone resistance in food-borne infections with
almonella and campylobacter acquired domesti-
ally. In Europe there is a clear association between
he levels of antibiotic resistant E. coli causing
lood stream infections in different countries and
he levels of resistance in poultry and pig E. coli
solates [11].
Colonization of food chain animals by E. coli-
SBL is quite high and increasing. In Switzerland in
011, it was of 15% in pigs, which is over that of
he local human population [12] and as high a 25%
n calves and 63% in chicken which might be in rela-
ion with speciﬁc usage of cephalosporins in these
nimals. The widespread practice of injecting 3rd
eneration cephalosporin (e.g. ceftiofur) into eggs
ust before they hatch appears to be the major con-
ributor to this problem [13]. In Germany, 38% of the
hicken were colonized with a variety of ESBL genes
nd retail chicken meat might be a reservoir for
trains or ESBL genes for humans [14]. In Spain the
revalence of E. coli-ESBL in poultry meat increased
rom 62.5% in 2007 to 93.3% in 2010. Consumption
f retail meat by women is associated with a three-
old risks that strain are resistant in case of UTI
15].
ensity of colonization
ensities of ESBL strains in the feces of colo-
ized animals can vary greatly by several orders
f magnitude some being categorized as high den-
ity shedders or super shedders [16]. In humans
igh densities of colonization is associated with
ncrease dissemination [17]. Thus, consequences
f such variations in food chain animals should be
nvestigated in further details.
enetic evidences of transfer
hen looking at the distribution of enzymes that
ause the ESBL phenotypes, striking differences are
bserved depending on the origin of the strains
animal or humans, or between animal species)
18]. Some, such as CTX-M1 are however found
cross all species, suggesting that some trans-
ission does indeed occur. Differences observed
etween species in the distribution of ESBL enzymes
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are not greater than those observed between
fecal and blood isolates in humans [19]. Plots
of the phylogenetic relationships between ESBL
E. coli from chicken, human feces and human
blood show no clear differential patterns suggesting
that transfer does indeed occur with a signiﬁ-
cant rate. High resolution power genetic tools with
increased resolution power are highly conclusive
that food chain animals can be the source of EBSL
in humans but cannot estimate the precise rate
of transfer [20]. This is currently addressed for
instance by the EvoTar 7th European Union Research
program (http://www.evotar.eu) which character-
izes antibiotic resistance genes from the human
microbiome and elucidates its interactions with
environmental, animal and food reservoirs of resis-
tance.
Organic food
Whether organic products are less likely than con-
ventional ones to carry resistant bacteria is a fre-
quently asked by consumers. In France, there were
no signiﬁcant differences in rates and densities of
colonization by resistant bacteria between organic
and conventional fruits and vegetables eaten raw
[3]. This however is not be the same for meat,
ESBL contamination appearing signiﬁcantly less fre-
quent and less dense in organic than in conventional
retail chicken meat [21]. When resistant bacteria
are widespread in food animals, it is very likely
that soil and waterways contaminated with fecal
material and efﬂuent from farm animals will carry
resistant bacteria. These can then go onto colonize
fruits and vegetables, even if raised organically.
Certainly more studies are needed in the ﬁeld.
The AGISAR initiative
It is obvious that food chain animals are a signiﬁ-
cant reservoir of resistance for human pathogens.
Although the magnitude of this source in compar-
ison of the direct selection of resistance due to
antibiotic use in humans remains unknown and will
vary for different groups of bacteria, this obvious
important factor certainly needs to be taken into
account at a time where no new antibiotic are avail-
able, which forces to consider those on the market
as a ‘‘limited resource’’ to be preserve for infected
patients who need it.This is in this context that has been launched
in December 2008 the WHO-AGISAR (World Health
Organization Advisory Group on Integrated Surveil-
lance of Antimicrobial Resistance) initiative. It wasA. Aidara-Kane et al.
stablished to support WHO’s effort to minimize
he public health impact of antimicrobial resis-
ance associated with the use of antimicrobials in
ood animals. In particular, the Advisory Group will
ssist WHO on matters related to the integrated
urveillance of antimicrobial resistance and the
ontainment of food-related antimicrobial resis-
ance. The terms of reference of WHO-AGISAR
re (i) Develop harmonized schemes for monitor-
ng antimicrobial resistance in zoonotic and enteric
acteria using appropriate sampling, (ii) Sup-
ort WHO capacity-building activities in Member
ountries for antimicrobial resistance monitoring
AMR training modules for Global Foodborne Infec-
ions Network (GFN) training courses), (iii) Promote
nformation sharing on AMR, (iv) Provide expert
dvice to WHO on containment of antimicro-
ial resistance with a particular focus on Human
ritically Important Antimicrobials, (v) Support
nd advise WHO on the selection of sentinel
ites and the design of pilot projects for con-
ucting integrated surveillance of antimicrobial
esistance and (vi) Support WHO capacity-building
ctivities in Member countries for antimicrobial
sage monitoring. The WHO-AGISAR comprises over
0 internationally renowned experts in a broad
ange of disciplines relevant to antimicrobial resis-
ance, appointed following a web-published call for
dvisers, and a transparent selection process. WHO-
GISAR holds quarterly telephone conferences and
nnual face-to-face meetings.
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